Crossmark

Phase 2A Learnings Incorporated into RewinD-LB, a Phase 2B Clinical Trial of Neflamapimod in Dementia with Lewy Bodies

Crossref DOI link: https://doi.org/10.14283/jpad.2024.36

Published Print: 2024-05

Update policy: https://doi.org/10.1016/elsevier_cm_policy

Authors

Prins, N.D.

de Haan, W.

Gardner, A.

Blackburn, K.

Chu, H.-M.

Galvin, J.E.

Alam, John J.
License Information

Text and Data Mining valid from 2024-05-01

Text and Data Mining valid from 2024-05-01

Version of Record valid from 2024-02-09
More Information

This article is maintained by: Elsevier

Article Title: Phase 2A Learnings Incorporated into RewinD-LB, a Phase 2B Clinical Trial of Neflamapimod in Dementia with Lewy Bodies

Journal Title: The Journal of Prevention of Alzheimer's Disease

CrossRef DOI link to publisher maintained version: https://doi.org/10.14283/jpad.2024.36

Content Type: article

Copyright: Copyright © 2024 THE AUTHORS. Published by Elsevier Masson SAS on behalf of SERDI Publisher. Published by Elsevier Masson SAS